Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complementKIMURA, Yuko; MIWA, Takashi; LIN ZHOU et al.Blood. 2008, Vol 111, Num 2, pp 732-740, issn 0006-4971, 9 p.Article

Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cellsWUDING ZHOU; PATEL, Hetal; KE LI et al.Blood. 2006, Vol 107, Num 6, pp 2461-2469, issn 0006-4971, 9 p.Article

Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavageFUNG, M; LU, M; FURE, H et al.Clinical and experimental immunology (Print). 2003, Vol 133, Num 2, pp 160-169, issn 0009-9104, 10 p.Article

Concerted clearance of immune complexes bound to the human erythrocyte complement receptor : Development of a heterologous mouse modelHENDERSON, Andrea L; LINDORFER, Margaret A; KENNEDY, Adam D et al.Journal of immunological methods. 2002, Vol 270, Num 2, pp 183-197, issn 0022-1759, 15 p.Article

Distribution of rat C5a anaphylatoxin receptorAKATSU, Hiroyasu; ABE, Masayoshi; MIWA, Takashi et al.Microbiology and immunology. 2002, Vol 46, Num 12, pp 863-874, issn 0385-5600, 12 p.Article

Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammationMOLLNES, Tom Eirik; BREKKE, Ole-Lars; FUNG, Michael et al.Blood. 2002, Vol 100, Num 5, pp 1869-1877, issn 0006-4971, 9 p.Article

XIX International Complement Workshop, September 22-26, 2002, Palermo, Italy: AbstractsInternational immunopharmacology. 2002, Vol 2, Num 9, issn 1567-5769, 186 p.Conference Proceedings

Human blood platelet gC1qR/p33PEERSCHKE, Ellinor I. B; GHEBREHIWET, Berhane.Immunological reviews. 2001, Vol 180, pp 56-64, issn 0105-2896Article

Structural biology of C1: dissection of a complex molecular machineryARLAUD, Gérard J; GABORIAUD, Christine; THIELENS, Nicole M et al.Immunological reviews. 2001, Vol 180, pp 136-145, issn 0105-2896Article

Functions of anaphylatoxin C5a in rat liver : direct and indirect actions on nonparenchymal and parenchymal cellsSCHIEFERDECKER, Henrike L; SCHLAF, Gerald; JUNGERMANN, Kurt et al.International immunopharmacology. 2001, Vol 1, Num 3, pp 469-481, issn 1567-5769Conference Paper

Plasma C3a and C4a levels in liver transplant recipients : A longitudinal studyPFEIFER, P. H; BREMS, J. J; BRUNSON, M et al.Immunopharmacology (New York). 2000, Vol 46, Num 2, pp 163-174, issn 0162-3109Article

The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiencyHØGASEN, A. K. M; ØVERLIE, I; HANSEN, T. W. R et al.Journal of perinatal medicine. 2000, Vol 28, Num 1, pp 39-48, issn 0300-5577Article

Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1HOURCADE, D; LISZEWSKI, M. K; KRYCH-GOLDBERG, M et al.Immunopharmacology (New York). 2000, Vol 49, Num 1-2, pp 103-116, issn 0162-3109Conference Paper

Complement and innate immunitySONG, W.-C; SARRIAS, M. R; LAMBRIS, J. D et al.Immunopharmacology (New York). 2000, Vol 49, Num 1-2, pp 187-198, issn 0162-3109Conference Paper

NF-κB activation is required for C5a-induced interleukin-8 gene expression in mononuclear cellsHSU, M. H; MEIYING WANG; BROWNING, D. D et al.Blood. 1999, Vol 93, Num 10, pp 3241-3249, issn 0006-4971Article

mRNA expression of complement components and regulators in rat arterial smooth muscle cellsWENXIN LI; TADA, T; MIWA, T et al.Microbiology and immunology. 1999, Vol 43, Num 6, pp 585-593, issn 0385-5600Article

Rôle de la protéine C3 du système complémentaire dans le contrôle de la réponse immunitaire spécifique = Role of the complement C3 protein in the control of the specific immune responseVILLIERS, C. L; VILLIERS, M.-B; MARCHE, P. N et al.Annales de biologie clinique (Paris). 1999, Vol 57, Num 2, pp 127-135, issn 0003-3898Article

Derivation of RNA aptamer inhibitors of human complement C5BIESECKER, G; DIHEL, L; ENNEY, K et al.Immunopharmacology (New York). 1999, Vol 42, Num 1-3, pp 219-230, issn 0162-3109Conference Paper

Structure and functions of proteases which cleave human C3 and are expressed on normal or tumor human cells : some are involved in tumorigenic and metastatic properties of human melanoma cellsFRADE, R.Immunopharmacology (New York). 1999, Vol 42, Num 1-3, pp 39-45, issn 0162-3109Conference Paper

Pharmacological characterization of antagonists of the C5a receptorPACZKOWSKI, N. J; FINCH, A. M; WHITMORE, J. B et al.British journal of pharmacology. 1999, Vol 128, Num 7, pp 1461-1466, issn 0007-1188Article

Effect of complement on the rheological properties of the erythrocyte membraneALMARA, A; VALVERDE, J; GENNARO, A. M et al.Clinical hemorheology. 1998, Vol 19, Num 1, pp 7-16, issn 0271-5198Conference Paper

Stability of C3 convertase in the rat classical complement pathwayNAITO, A; OKADA, H.Microbiology and immunology. 1997, Vol 41, Num 8, pp 621-624, issn 0385-5600Article

Structure et fonction d'une protéase modulaire. Etude de la Région Catalytique de la Sous-Unité C1s du Complexe C1 du Complément Humain = Structure and function of a modular protease: Study of the Catalytic Region of the C1s subunit of the Human Complement C1 ComplexRossi, Véronique; Arlaud, Gérard.1997, 300 p.Thesis

The C5a chemoattractant receptor mediates mucosal defense to infectionHÖPKEN, U. E; LU, B; GERARD, N. P et al.Nature (London). 1996, Vol 383, Num 6595, pp 86-89, issn 0028-0836Article

Activation of the endothelium by IL-1α and glucocorticoids results in major increase of complement C3 and factor B production and generation of C3aCOULPIER, M; ANDREEV, S; LEMERCIER, C et al.Clinical and experimental immunology (Print). 1995, Vol 101, Num 1, pp 142-149, issn 0009-9104Article